Product Name: Human TNFSF13 / APRIL / CD256 Antibody (Sibeprenlimab, Research Use)
Catalog Number: NBR-0914
Target Name: TNFSF13 / APRIL / CD256
Trade Name: Sibeprenlimab
Antibody Drug Description: Sibeprenlimab, a humanized IgG 2 monoclonal antibody that inhibits APRIL, is being developed as a potential treatment for IgA nephropathy (IgAN). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: TNFSF13
Synonyms: APRIL; CD256
Target Description: Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. Plays a role in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
Ensembl:  ENSG00000161955
Uniprot:  O75888